Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 12:57 pm Sale | 2025-12-31 | 13G | XTANT MED HLDGS INC XTNT | LYTTON LAURENCE W | 7,702,002 5.500% | -1,761,440 (-18.61%) | Filing History |
| 2025-08-05 4:30 pm Unchanged | 2025-08-01 | 13D | XTANT MED HLDGS INC XTNT | Nantahala Capital Management, LLC | 68,394,000 49.100% | 0 (Unchanged) | Filing History |
| 2025-04-17 4:31 pm Purchase | 2025-04-10 | 13D | XTANT MED HLDGS INC XTNT | Nantahala Capital Management, LLC | 68,394,000 49.100% | 57,000,000 (+500.26%) | Filing History |
| 2025-04-16 2:11 pm Purchase | 2025-04-15 | 13G | XTANT MED HLDGS INC XTNT | LYTTON LAURENCE W | 9,463,442 6.800% | 9,463,442 (New Position) | Filing History |
| 2025-04-14 7:09 pm Sale | 2025-04-10 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 0 0.000% | -73,114,592 (Position Closed) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | XTANT MED HLDGS INC XTNT | Nantahala Capital Management, LLC | 11,394,000 8.214% | 11,394,000 (New Position) | Filing History |
| 2024-09-10 4:12 pm Unchanged | 2024-09-03 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 52.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:10 pm Purchase | 2023-12-31 | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LLC | 8,027,593 6.200% | 1,529,675 (+23.54%) | Filing History |
| 2023-08-03 4:59 pm Unchanged | 2023-08-01 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 56.700% | 0 (Unchanged) | Filing History |
| 2023-05-05 11:14 am Unchanged | 2023-05-01 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:51 pm Unchanged | 2022-12-31 | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LLC | 6,497,918 5.700% | 0 (Unchanged) | Filing History |
| 2022-09-06 2:19 pm Purchase | 2022-08-25 | 13D | XTANT MED HLDGS INC XTNT | Vizirgianakis Stavros G. | 7,224,924 6.620% | 7,224,924 (New Position) | Filing History |
| 2022-08-30 4:37 pm Purchase | 2022-08-26 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.900% | 241,098 (+0.33%) | Filing History |
| 2022-02-11 9:13 pm Sale | 2021-12-31 | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LLC | 6,497,918 7.200% | -2,165,971 (-25.00%) | Filing History |